Jeff Cislini - Mar 1, 2024 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Role: General Counsel
Signature: /s/ Jack Anders, as Attorney-in-fact for Jeff Cislini
Stock symbol: RVMD
Transactions as of: Mar 1, 2024
Transactions value $: $0
Form type: 4
Date filed: 3/5/2024, 04:54 PM
Previous filing: Jan 24, 2024
Next filing: Mar 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RVMD	Common Stock	Award	$0	+21K	+58.13%	$0.00	57.1K	Mar 1, 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RVMD	Stock Option (Right to Buy)	Award	$0	+73.5K		$0.00	73.5K	Mar 1, 2024	Common Stock	73.5K	$29.80	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes 52,417 restricted stock units.
F2	One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.

Content

Includes 52,417 restricted stock units.

One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2024 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.